FR EN

Update of The Pioneer Project: 444 patients in the biomarker program, 80 patients in the umbrella clinical trial

Date : 30 November 2022
Category : MI Live,News,Pioneer Project


As of November 30th, 2022, 17 partner centers are recruiting patients for the biomarker component of The Pioneer Project:

Hôpital Nord/AP-HM, Hôpital Européen and Hôpital Saint Joseph (Marseille), Hôpital Larrey/Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Hôpital Sainte Musse (Toulon), Centre Hospitalier d’Annecy, Centre Hospitalier Vallées de l’Ariège (Foix), Hôpital Nord-Ouest (Villefranche-sur- Saône), Centre Hospitalier Henri Duffaut  (Avignon), Centre Hospitalier de Cahors, Centre Hospitalier du Pays d’Aix (Aix-en-Provence), Centre Hospitalier de Montauban, Centre Hospitalier de Bastia, Clinique Maymard (Bastia), ONCOGARD Nîmes and Alès.

491 patients have been screened, of which 444 have entered the biomarker component of the project (98.7% of total inclusions). In parallel, 114 patients have been screened for and 80 have entered the PIONeeR umbrella clinical trial (66.7% of total inclusions).

PIONeeR BIOMARKERS

Centre

Nombre de patients screenés

Number of patients screened

Nombre de patients inclus

Number of patients included

Hôpital Nord - Marseille

216

195

Oncopole Toulouse

29

28

CLB Lyon

34

30

Clinique Maymard - Bastia

4

3

Hôpital Européen - Marseille

12

12

Hôpital Saint Joseph - Marseille

40

36

CH Toulon

44

38

CH Aix Pertuis

29

29

CH Bastia

3

3

CH Avignon

18

13

CH Nîmes

16

14

Oncogard

11

11

Cahors

3

3

CHIVA

9

7

Montauban

3

3

Annecy

5

4

CH Villefranche-sur-Saône

15

15

Total

491

444

PIONeeR TRIAL

Centre

Nombre de patients screenés

Number of patients screened

Nombre de patients inclus

Number of patients included

CEPCM Marseille

78

54

Oncopole Toulouse

16

12

CLC Léon Bérard, Lyon

20

14

Total

114

80

 


Back